Good Works II Acquisition Corp.

If you purchased Good Works II Acquisition Corp. securities and would like to join the action, please click "Join This Action" below.


October 17, 2022.

New York, New York—Halper Sadeh LLC, a global investor rights law firm, is investigating whether the merger of Good Works II Acquisition Corp. (NASDAQ: GWII), a publicly traded special purpose acquisition company, and Direct Biologics, LLC, a late-stage biotechnology company, is fair to Good Works shareholders.

The investigation concerns whether Good Works and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Good Works shareholders; and (2) disclose all material information necessary for Good Works shareholders to adequately assess and value the merger consideration. On behalf of Good Works shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Scroll to Top